Plasma pregnancy-associated alpha 2-glycoprotein concentrations in complications of pregnancy and foetal abnormality.
Maternal plasma concentrations of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) were measured in normal pregnancy and in pregnancies complicated by apparent threatened abortion, pre-eclampsia or intrauterine growth retardation (IUGR). alpha 2-PAG levels were significantly decreased in those women who spontaneously aborted and in those with foetal death, but were unaffected in patients who threatened to abort and in whom pregnancy continued successfully. Concentrations of alpha 2-PAG were also unaffected in subjects with mild or severe pre-eclampsia and in those with IUGR. Patients with high alpha-foetoprotein levels associated with foetal abnormality also had normal alpha 2-PAG levels for stage of gestation. The possible immunological implications of these findings are discussed.
D000022:Abortion, Spontaneous; D005260:Female; D005317:Fetal Growth Retardation; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D011225:Pre-Eclampsia; D011247:Pregnancy; D011248:Pregnancy Complications; D000509:alpha-Fetoproteins
D006023:Glycoproteins; D000509:alpha-Fetoproteins